Epalrestat
Epalrestat No CAS: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat úsase para previr, mellorar e tratar a neuropatía periférica (adormecemento, dor), parestesia vibracional e anomalía cardíaca asociada á diabetes. ESPECIFICACIÓN
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat úsase para previr, mellorar e tratar a neuropatía periférica (adormecemento, dor), parestesia vibracional e anomalía cardíaca asociada á diabetes. ESPECIFICACIÓN
P roduto nome | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Escribe aquí a túa mensaxe e mándana